CLDN2 and colorectal cancer: The bulk of existing studies on claudin-2 in the gastrointestinal tract concerns colorectal cancer, where it is upregulated in response to IL-4 and IL-13 [16] and involved in promoting proliferation, survival, migration, colony formation, and drug resistance [16,36,37].